← Back to Search

Behavioural Intervention

Patient Navigation for Primary Hyperparathyroidism

N/A
Recruiting
Led By Rachel Kelz, MD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Prior Parathyroidectomy
End-stage Renal Disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at 6 and 12 months after recruitment or surgery in all groups
Awards & highlights

Summary

This trial aims to investigate how patient navigation can improve surgical outcomes for individuals with primary hyperparathyroidism (PHPT) who have been historically marginalized. The study will focus on the impact of patient

Who is the study for?
This trial is for individuals with primary hyperparathyroidism, particularly those from historically marginalized communities. The study aims to improve their access to surgery. Specific eligibility criteria are not provided, but typically include a confirmed diagnosis and being within a certain age range.
What is being tested?
The study is testing the effectiveness of 'Scheduling Navigation' compared to standard approaches without such assistance. It looks at whether this helps patients get surgical consultations and surgeries faster, and if it increases the number of patients getting surgery.
What are the potential side effects?
Since this trial focuses on scheduling navigation rather than medical treatments or interventions, there are no direct side effects related to medications or procedures. However, participants may experience stress or anxiety related to scheduling and attending appointments.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had surgery to remove my parathyroid glands.
Select...
My kidneys are in the final stage of failure.
Select...
I have had a kidney transplant.
Select...
My cancer has spread to other parts of my body.
Select...
I have been diagnosed with Familial Hypocalciuric Hypercalcemia.
Select...
I am not a candidate for surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at 6 and 12 months after recruitment or surgery in all groups
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at 6 and 12 months after recruitment or surgery in all groups for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Parathyroidectomy Surgical Outcome
Secondary study objectives
Completion of Consultation
Complications related to hyperparathyroidism
Parathyroidectomy complications
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Scheduling NavigationExperimental Treatment1 Intervention
Participants will be assigned to a scheduler.
Group II: Without Scheduling NavigationActive Control1 Intervention
Participants will not be assigned to a scheduler.

Find a Location

Who is running the clinical trial?

American College of SurgeonsOTHER
16 Previous Clinical Trials
60,209 Total Patients Enrolled
University of PennsylvaniaLead Sponsor
2,053 Previous Clinical Trials
43,013,051 Total Patients Enrolled
Rachel Kelz, MDPrincipal InvestigatorUniversity of Pennsylvania
1 Previous Clinical Trials
60 Total Patients Enrolled
~51 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top